Literature DB >> 21452052

Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells.

G Dong1, J M Ferguson, A J Duling, R G Nicholas, D Zhang, K Rezvani, S Fang, M J Monteiro, S Li, X-J Li, H Wang.   

Abstract

Huntington's disease (HD) is caused by an abnormal expansion of CAG trinucleotide repeats encoding polyglutamine (polyQ) in the first exon of the huntingtin (htt) gene. Despite considerable efforts, the pathogenesis of HD remains largely unclear due to a paucity of models that can reliably reproduce the pathological characteristics of HD. Here, we report a neuronal cell model of HD using the previously established tetracycline regulated rat neuroprogenitor cell line, HC2S2. Stable expression of enhanced green fluorescence protein tagged htt exon 1 (referred to as 28Q and 74Q, respectively) in the HC2S2 cells did not affect rapid neuronal differentiation. However, compared to the cells expressing wild type htt, the cell line expressing mutant htt showed an increase in time-dependent cell death and neuritic degeneration, and displayed increased vulnerability to oxidative stress. Increased protein aggregation during the process of neuronal aging or when the cells were exposed to oxidative stress reagents was detected in the cell line expressing 74Q but not in its counterpart. These results suggest that the neuroprogenitor cell lines mimic the major neuropathological characteristics of HD and may provide a useful tool for studying the neuropathogenesis of HD and for high throughput screening of therapeutic compounds.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21452052      PMCID: PMC3724999          DOI: 10.1007/s10571-011-9679-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  40 in total

1.  Interacting proteins as genetic modifiers of Huntington disease.

Authors:  Xiao-Jiang Li; Meyer Friedman; Shihua Li
Journal:  Trends Genet       Date:  2007-10-24       Impact factor: 11.639

2.  Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Biochem Biophys Res Commun       Date:  2007-06-25       Impact factor: 3.575

3.  Tandem affinity purification of protein complexes from mammalian cells by the Strep/FLAG (SF)-TAP tag.

Authors:  Christian Johannes Gloeckner; Karsten Boldt; Annette Schumacher; Marius Ueffing
Journal:  Methods Mol Biol       Date:  2009

Review 4.  Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.

Authors:  Edward C Stack; Wayne R Matson; Robert J Ferrante
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

5.  A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.

Authors:  Maria Stella Lombardi; Leonie Jaspers; Christine Spronkmans; Cinzia Gellera; Franco Taroni; Emilio Di Maria; Stefano Di Donato; William F Kaemmerer
Journal:  Exp Neurol       Date:  2009-03-13       Impact factor: 5.330

Review 6.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

7.  Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.

Authors:  Rona K Graham; Mahmoud A Pouladi; Prasad Joshi; Ge Lu; Yu Deng; Nan-Ping Wu; Bryan E Figueroa; Martina Metzler; Véronique M André; Elizabeth J Slow; Lynn Raymond; Robert Friedlander; Michael S Levine; Blair R Leavitt; Michael R Hayden
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

8.  Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.

Authors:  Caroline L Benn; Tingting Sun; Ghazaleh Sadri-Vakili; Karen N McFarland; Derek P DiRocco; George J Yohrling; Timothy W Clark; Bérengère Bouzou; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

9.  Effects of overexpression of huntingtin proteins on mitochondrial integrity.

Authors:  Hongmin Wang; Precious J Lim; Mariusz Karbowski; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2008-11-27       Impact factor: 6.150

10.  Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease.

Authors:  Willeke M C van Roon-Mom; Barry A Pepers; Peter A C 't Hoen; Carola A C M Verwijmeren; Johan T den Dunnen; Josephine C Dorsman; Gertjan B van Ommen
Journal:  BMC Mol Biol       Date:  2008-10-09       Impact factor: 2.946

View more
  11 in total

1.  Multiple phenotypes in Huntington disease mouse neural stem cells.

Authors:  James J Ritch; Antonio Valencia; Jonathan Alexander; Ellen Sapp; Leah Gatune; Gavin R Sangrey; Saurabh Sinha; Cally M Scherber; Scott Zeitlin; Ghazaleh Sadri-Vakili; Daniel Irimia; Marian Difiglia; Kimberly B Kegel
Journal:  Mol Cell Neurosci       Date:  2012-04-06       Impact factor: 4.314

2.  Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.

Authors:  Yanying Liu; Casey L Hettinger; Dong Zhang; Khosrow Rezvani; Xuejun Wang; Hongmin Wang
Journal:  J Neurochem       Date:  2014-01-18       Impact factor: 5.372

3.  Prothymosin-α interacts with mutant huntingtin and suppresses its cytotoxicity in cell culture.

Authors:  Gaofeng Dong; Eduardo A Callegari; Christian J Gloeckner; Marius Ueffing; Hongmin Wang
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

4.  Heat Shock-Induced Extracellular Vesicles Derived from Neural Stem Cells Confer Marked Neuroprotection Against Oxidative Stress and Amyloid-β-Caused Neurotoxicity.

Authors:  Christa C Huber; Eduardo A Callegari; Maria D Paez; Svetlana Romanova; Hongmin Wang
Journal:  Mol Neurobiol       Date:  2022-10-03       Impact factor: 5.682

Review 5.  Pluripotent stem cells models for Huntington's disease: prospects and challenges.

Authors:  Richard L Carter; Anthony W S Chan
Journal:  J Genet Genomics       Date:  2012-05-09       Impact factor: 4.275

6.  Adult neural progenitor cells from Huntington's disease mouse brain exhibit increased proliferation and migration due to enhanced calcium and ROS signals.

Authors:  Wenjuan Xie; Jiu-Qiang Wang; Qiao-Chu Wang; Yun Wang; Sheng Yao; Tie-Shan Tang
Journal:  Cell Prolif       Date:  2015-08-13       Impact factor: 6.831

7.  FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.

Authors:  Yanying Liu; Fangfang Qiao; Patricia C Leiferman; Alan Ross; Evelyn H Schlenker; Hongmin Wang
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

Review 8.  An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.

Authors:  G Cisbani; F Cicchetti
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

9.  Direct reprogramming of Huntington's disease patient fibroblasts into neuron-like cells leads to abnormal neurite outgrowth, increased cell death, and aggregate formation.

Authors:  Yanying Liu; Yuanchao Xue; Samantha Ridley; Dong Zhang; Khosrow Rezvani; Xiang-Dong Fu; Hongmin Wang
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

10.  Exogenous polyserine and polyleucine are toxic to recipient cells.

Authors:  Ryuji Owada; Shinichi Mitsui; Kazuhiro Nakamura
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.